PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RDY vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RDY and JNJ is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

RDY vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dr. Reddy's Laboratories Limited (RDY) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

-20.00%-15.00%-10.00%-5.00%0.00%5.00%SeptemberOctoberNovemberDecember2025February
-19.49%
-1.70%
RDY
JNJ

Key characteristics

Sharpe Ratio

RDY:

-0.21

JNJ:

0.22

Sortino Ratio

RDY:

-0.14

JNJ:

0.44

Omega Ratio

RDY:

0.98

JNJ:

1.05

Calmar Ratio

RDY:

-0.24

JNJ:

0.20

Martin Ratio

RDY:

-0.52

JNJ:

0.48

Ulcer Index

RDY:

9.04%

JNJ:

7.24%

Daily Std Dev

RDY:

22.30%

JNJ:

16.23%

Max Drawdown

RDY:

-58.55%

JNJ:

-52.60%

Current Drawdown

RDY:

-19.49%

JNJ:

-8.96%

Fundamentals

Market Cap

RDY:

$11.49B

JNJ:

$373.16B

EPS

RDY:

$0.74

JNJ:

$5.79

PE Ratio

RDY:

18.32

JNJ:

26.77

PEG Ratio

RDY:

4.51

JNJ:

0.99

Total Revenue (TTM)

RDY:

$317.20B

JNJ:

$88.82B

Gross Profit (TTM)

RDY:

$189.51B

JNJ:

$61.35B

EBITDA (TTM)

RDY:

$69.94B

JNJ:

$28.53B

Returns By Period

In the year-to-date period, RDY achieves a -14.12% return, which is significantly lower than JNJ's 8.03% return. Over the past 10 years, RDY has underperformed JNJ with an annualized return of 4.41%, while JNJ has yielded a comparatively higher 7.41% annualized return.


RDY

YTD

-14.12%

1M

-8.99%

6M

-18.49%

1Y

-4.58%

5Y*

12.12%

10Y*

4.41%

JNJ

YTD

8.03%

1M

6.26%

6M

-0.92%

1Y

2.18%

5Y*

3.90%

10Y*

7.41%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RDY vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDY
The Risk-Adjusted Performance Rank of RDY is 3131
Overall Rank
The Sharpe Ratio Rank of RDY is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of RDY is 2727
Sortino Ratio Rank
The Omega Ratio Rank of RDY is 2828
Omega Ratio Rank
The Calmar Ratio Rank of RDY is 3131
Calmar Ratio Rank
The Martin Ratio Rank of RDY is 3535
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 4848
Overall Rank
The Sharpe Ratio Rank of JNJ is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 4242
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 4141
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 5555
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 5151
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RDY vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RDY, currently valued at -0.21, compared to the broader market-2.000.002.004.00-0.210.22
The chart of Sortino ratio for RDY, currently valued at -0.14, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.140.44
The chart of Omega ratio for RDY, currently valued at 0.98, compared to the broader market0.501.001.502.000.981.05
The chart of Calmar ratio for RDY, currently valued at -0.24, compared to the broader market0.002.004.006.00-0.240.20
The chart of Martin ratio for RDY, currently valued at -0.52, compared to the broader market0.0010.0020.0030.00-0.520.48
RDY
JNJ

The current RDY Sharpe Ratio is -0.21, which is lower than the JNJ Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of RDY and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00SeptemberOctoberNovemberDecember2025February
-0.21
0.22
RDY
JNJ

Dividends

RDY vs. JNJ - Dividend Comparison

RDY's dividend yield for the trailing twelve months is around 7.07%, more than JNJ's 3.20% yield.


TTM20242023202220212020201920182017201620152014
RDY
Dr. Reddy's Laboratories Limited
7.07%6.07%4.21%7.39%0.52%0.46%0.71%3.94%0.83%3.28%3.37%3.00%
JNJ
Johnson & Johnson
3.20%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

RDY vs. JNJ - Drawdown Comparison

The maximum RDY drawdown since its inception was -58.55%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for RDY and JNJ. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-19.49%
-8.96%
RDY
JNJ

Volatility

RDY vs. JNJ - Volatility Comparison

Dr. Reddy's Laboratories Limited (RDY) has a higher volatility of 8.67% compared to Johnson & Johnson (JNJ) at 5.79%. This indicates that RDY's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February
8.67%
5.79%
RDY
JNJ

Financials

RDY vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Dr. Reddy's Laboratories Limited and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab